Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Austria bans bovine catgut in surgical suturing:

This article was originally published in Clinica

Executive Summary

The Austrian government has moved to ban the use of catgut, made from bovine intestines, in surgical suturing, following a warning by the European Commission. Catgut can be "almost completely" replaced by synthetic suturing, the government believes. In cases where a replacement is not available, it advises doctors to use CE-marked catgut that originates from a country where the risk of BSE is relatively low (for example Argentina, Paraguay, Norway and New Zealand). The ban coincides with similar moves by the German government (see Clinica No 944, p 4).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT069871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel